Sanjay Mehta - Aug 14, 2023 Form 4 Insider Report for TERADYNE, INC (TER)

Signature
/s/ Ryan E. Driscoll, Attorney-in-Fact
Stock symbol
TER
Transactions as of
Aug 14, 2023
Transactions value $
-$2,290,812
Form type
4
Date filed
8/16/2023, 05:01 PM
Previous filing
May 3, 2023
Next filing
Jan 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TER Common Stock Options Exercise $247K +5.08K +8.81% $48.74 62.7K Aug 14, 2023 Direct F1, F3
transaction TER Common Stock Sale -$666K -6.55K -10.44% $101.76 56.2K Aug 14, 2023 Direct F1, F4
transaction TER Common Stock Sale -$269K -2.62K -4.66% $102.74 53.6K Aug 14, 2023 Direct F1, F5
transaction TER Common Stock Sale -$1.12M -10.8K -20.21% $103.85 42.7K Aug 14, 2023 Direct F1, F6
transaction TER Common Stock Sale -$479K -4.58K -10.72% $104.54 38.2K Aug 14, 2023 Direct F1, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TER Stock Option (Right to Buy) Options Exercise $0 -5.08K -100% $0.00* 0 Aug 14, 2023 Common Stock 5.08K $48.74 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported transactions were effected pursuant to a sales plan adopted by the Reporting Person on May 12, 2023 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2 This option was granted under the Issuer's 2006 Equity and Cash Compensation Incentive Plan, and became exercisable at the rate of 25% per year commencing on May 1, 2020, the first anniversary of the grant.
F3 Includes 112.2675 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2023.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $101.28 to $102.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $102.35 to $103.15. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $103.29 to $104.28. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $104.30 to $104.72. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.